• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN RAPIDCROSS; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN RAPIDCROSS; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Catalog Number A14BX030210170
Device Problems Entrapment of Device (1212); Detachment of Device or Device Component (2907)
Patient Problem Injury (2348)
Event Date 10/09/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician intended to use a rapidcross 0.014" rx pta balloon catheter as part of the procedure on the anterior tibial artery.The mid lesion was moderately calcified.The sheath was a non-medtronic 5f device.There was no embolic protection used.The balloon was inflated with a non-medtronic inflation device.The ifu was followed during the preparation and procedure.It was reported that the physician had finished the procedure and the balloon was stuck in the artery.There was heavy resistance felt when trying to retrieve the device.Excessive force was used, causing the balloon to separate from the catheter, leaving fragments in the artery.The procedure was complete by the physician using a snare to retrieve the fragments.No patient injury was reported.
 
Manufacturer Narrative
Additional information: the lesion exhibited 70% stenosis.The balloon was inflated to 8atm.The balloon was fully deflated when the issue occurred.No vessel damage occurred as a result of this issue.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Product analysis: the rapidcross dilation catheter was received for analysis.No ancillary device nor procedural cines were received for evaluation.The rapidcross catheter was received in three segments.A proximal segment including the manifold loaded in transportation hoop, and two loose segments.An inventory of the rapidcross catheter concluded that all components were accounted for.The proximal segment terminated at the proximal wire port and exhibited tensile stretching.The proximal guidewire segment exhibited tensile stretching at the proximal wire port.The proximal wire port exhibits ¿pitcher mouth¿ deformation most likely caused due to wire prolapse.The proximal marker band was accounted for.The proximal balloon terminated at a radial tear.The distal segment included the inner guidewire lumen, middle marker bands, distal marker band, distal tip and balloon chamber material.The proximal end of the balloon chamber material exhibited a radial tear and bunching up of the balloon chamber material.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAPIDCROSS
Type of Device
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9184445
MDR Text Key163159708
Report Number2183870-2019-00497
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130911
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/01/2022
Device Catalogue NumberA14BX030210170
Device Lot NumberA875732
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/18/2019
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/09/2019
Initial Date FDA Received10/14/2019
Supplement Dates Manufacturer Received10/14/2019
01/09/2020
Supplement Dates FDA Received10/15/2019
01/10/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/02/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-